Mass cytometry: a highly multiplexed single-cell technology for advancing drug development.

Abstract

Advanced single-cell analysis technologies (e.g., mass cytometry) that help in multiplexing cellular measurements in limited-volume primary samples are critical in bridging discovery efforts to successful drug approval. Mass cytometry is the state-of-the-art technology in multiparametric single-cell analysis. Mass cytometers (also known as cytometry by time… (More)
DOI: 10.1124/dmd.114.060798

Topics

Cite this paper

@article{Atkuri2015MassCA, title={Mass cytometry: a highly multiplexed single-cell technology for advancing drug development.}, author={Kondala R. Atkuri and Jeffrey C. Stevens and Hendrik Neubert}, journal={Drug metabolism and disposition: the biological fate of chemicals}, year={2015}, volume={43 2}, pages={227-33} }